clindamycin has been researched along with Vaginal Discharge in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aleri, JW; Annandale, CH; Ludbey, PA; Robertson, ID; Sahibzada, S; Tufail, MS; Valenzuela, JL; Waichigo, FK | 1 |
| Boers, K; Knetsch, CW; Kuijper, EJ; Leverstein-van Hall, MA; Molijn, A; van den Munckhof, EHA; Zwittink, RD | 1 |
| Baumgartner-Nielsen, J; Johannsen, E; Meinert, M | 1 |
| Gibson, MV; Hainer, BL | 1 |
| French, L; Horton, J; Matousek, M | 1 |
2 review(s) available for clindamycin and Vaginal Discharge
| Article | Year |
|---|---|
Vaginitis.
Topics: Administration, Intravaginal; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Atrophic Vaginitis; Bacterial Load; Candidiasis, Vulvovaginal; Clindamycin; Estrogens; Female; Gynecological Examination; Humans; Hydrogen-Ion Concentration; Metronidazole; Microscopy; Treatment Outcome; Trichomonas Vaginitis; Vaginal Discharge; Vaginosis, Bacterial | 2011 |
Abnormal vaginal discharge: what does and does not work in treating underlying causes.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Clindamycin; Female; Humans; Metronidazole; Nonprescription Drugs; Recurrence; Risk Factors; Self Medication; Sexually Transmitted Diseases; Trichomonas Vaginitis; United States; Vaginal Discharge; Vaginal Diseases; Vaginosis, Bacterial; Women's Health | 2004 |
4 other study(ies) available for clindamycin and Vaginal Discharge
| Article | Year |
|---|---|
A pilot study on bacterial isolates associated with purulent vaginal discharge in dairy cows in the south-west region of Western Australia.
Topics: Animals; Anti-Bacterial Agents; Cattle; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Endometritis; Enrofloxacin; Erythromycin; Escherichia coli; Female; Humans; Microbial Sensitivity Tests; Pilot Projects; Staphylococcus; Streptococcus; Vaginal Discharge; Western Australia | 2022 |
The vaginal microbiota in the course of bacterial vaginosis treatment.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Clindamycin; Female; Host Specificity; Humans; Metronidazole; Microbiota; RNA, Ribosomal, 16S; Vagina; Vaginal Discharge; Vaginosis, Bacterial | 2021 |
[In case of pelvic pain desquamative inflammatory vaginitis is an important differential diagnosis].
Topics: Adult; Anti-Bacterial Agents; Clindamycin; Critical Pathways; Diagnosis, Differential; Female; Humans; Pelvic Pain; Vaginal Discharge; Vaginitis | 2015 |
National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Drug Administration Schedule; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Vaginal Discharge; Vaginosis, Bacterial | 1999 |